Literature DB >> 15694179

Single cell quantification of the 8993T>G NARP mitochondrial DNA mutation by fluorescent PCR.

Nadine Gigarel1, Pierre F Ray, Philippe Burlet, Nelly Frydman, Ghislaine Royer, Sophie Lebon, Jean Paul Bonnefont, René Frydman, Arnold Munnich, Julie Steffann.   

Abstract

When a mitochondrial DNA (mtDNA) mutation is identified, the reliable and sensitive quantification of the mutation load is a prerequisite for evaluating the feasibility of prenatal/pregestational diagnosis of the disease. We have developed a quantification assay of the 8993T>G NARP mutation using semi-quantitative fluorescent PCR. The test was reproducible and the experimental values were linear even at extremely low concentrations of mutant mtDNA molecules, making quantification of the mutant load in individual cells feasible (including blastomeres). Studying single circulating lymphocytes from a single NARP 8993T>G patient, we found a broad distribution of the disease causing mutation (0-44%) supporting the remarkable variability of heteroplasmy at the cellular level. This observation and the experimental approach reported here should be relevant to either prenatal or preimplantation diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15694179     DOI: 10.1016/j.ymgme.2004.10.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  7 in total

1.  Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis.

Authors:  J Steffann; N Frydman; N Gigarel; P Burlet; P F Ray; R Fanchin; E Feyereisen; V Kerbrat; G Tachdjian; J-P Bonnefont; R Frydman; A Munnich
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

2.  Single lymphocytes from two healthy individuals with mitochondrial point heteroplasmy are mainly homoplasmic.

Authors:  Sabine Lutz-Bonengel; Timo Sänger; Walther Parson; Helena Müller; Joachim W Ellwart; Marie Follo; Bernhard Bonengel; Harald Niederstätter; Marielle Heinrich; Ulrike Schmidt
Journal:  Int J Legal Med       Date:  2007-10-06       Impact factor: 2.686

3.  Prenatal diagnosis of myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome: contribution to understanding mitochondrial DNA segregation during human embryofetal development.

Authors:  C Bouchet; J Steffann; J Corcos; S Monnot; V Paquis; A Rötig; S Lebon; P Levy; G Royer; I Giurgea; N Gigarel; A Benachi; Y Dumez; A Munnich; J P Bonnefont
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

4.  Poor correlations in the levels of pathogenic mitochondrial DNA mutations in polar bodies versus oocytes and blastomeres in humans.

Authors:  Nadine Gigarel; Laetitia Hesters; David C Samuels; Sophie Monnot; Philippe Burlet; Violaine Kerbrat; Frédéric Lamazou; Alexandra Benachi; René Frydman; Josué Feingold; Agnes Rotig; Arnold Munnich; Jean-Paul Bonnefont; Nelly Frydman; Julie Steffann
Journal:  Am J Hum Genet       Date:  2011-04-08       Impact factor: 11.025

5.  Purifying Selection against Pathogenic Mitochondrial DNA in Human T Cells.

Authors:  Melissa A Walker; Caleb A Lareau; Leif S Ludwig; Amel Karaa; Vijay G Sankaran; Aviv Regev; Vamsi K Mootha
Journal:  N Engl J Med       Date:  2020-08-12       Impact factor: 91.245

6.  Stability of the m.8993T->G mtDNA mutation load during human embryofetal development has implications for the feasibility of prenatal diagnosis in NARP syndrome.

Authors:  J Steffann; N Gigarel; J Corcos; M Bonnière; F Encha-Razavi; M Sinico; S Prevot; Y Dumez; A Yamgnane; R Frydman; A Munnich; J P Bonnefont
Journal:  J Med Genet       Date:  2007-06-01       Impact factor: 6.318

7.  Segregation of mtDNA throughout human embryofetal development: m.3243A>G as a model system.

Authors:  Sophie Monnot; Nadine Gigarel; David C Samuels; Philippe Burlet; Laetitia Hesters; Nelly Frydman; René Frydman; Violaine Kerbrat; Benoit Funalot; Jelena Martinovic; Alexandra Benachi; Josué Feingold; Arnold Munnich; Jean-Paul Bonnefont; Julie Steffann
Journal:  Hum Mutat       Date:  2011-01       Impact factor: 4.878

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.